Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
3.91B | 3.94B | 3.78B | 3.61B | 2.91B | 2.61B | Gross Profit |
1.54B | 1.59B | 1.31B | 1.31B | 1.05B | 933.70M | EBIT |
677.80M | 767.40M | 741.40M | 682.60M | 472.80M | 488.10M | EBITDA |
903.93M | 976.07M | 934.24M | 844.20M | 594.80M | 473.69M | Net Income Common Stockholders |
436.00M | 510.20M | 512.00M | 459.10M | 262.80M | 241.50M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
32.50M | 365.00M | 113.00M | 125.00M | 208.50M | 207.40M | Total Assets |
2.18B | 4.91B | 4.48B | 4.24B | 4.09B | 4.03B | Total Debt |
154.00M | 1.20B | 1.14B | 955.50M | 922.60M | 1.41B | Net Debt |
134.80M | 836.00M | 1.03B | 830.50M | 714.10M | 1.27B | Total Liabilities |
2.30B | 3.05B | 2.87B | 2.91B | 3.03B | 2.99B | Stockholders Equity |
-117.90M | 1.86B | 1.61B | 1.33B | 1.06B | 1.04B |
Cash Flow | Free Cash Flow | ||||
361.75M | 464.90M | 7.80M | 497.50M | 666.70M | 247.90M | Operating Cash Flow |
815.73M | 914.20M | 607.60M | 757.20M | 786.90M | 451.20M | Investing Cash Flow |
-467.27M | -470.50M | -660.10M | -348.20M | -120.40M | -203.80M | Financing Cash Flow |
-240.83M | -210.10M | -25.40M | -449.60M | -540.20M | -179.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | £56.43B | 16.60 | 16.07% | 1.72% | 1.78% | 15.53% | |
72 Outperform | $7.21B | 15.47 | 33.51% | 0.46% | 0.64% | -1.15% | |
72 Outperform | $31.12B | 34.39 | 11.79% | 0.79% | -4.68% | -1.73% | |
68 Neutral | $9.75B | 22.44 | 21.77% | ― | 1.26% | -17.38% | |
66 Neutral | $7.68B | 8.11 | 8.39% | 1.65% | -5.07% | 417.07% | |
63 Neutral | $28.98B | 14.67 | 22.83% | 0.65% | -3.56% | 70.93% | |
47 Neutral | $2.43B | -3.06 | -22.76% | 3.59% | 4.02% | -29.07% |